vs
Pediatrix Medical Group, Inc.（MD）与MSA Safety Inc（MSA）财务数据对比。点击上方公司名可切换其他公司
MSA Safety Inc的季度营收约是Pediatrix Medical Group, Inc.的1.0倍（$510.9M vs $493.8M），MSA Safety Inc净利率更高（17.0% vs 6.8%，领先10.2%），MSA Safety Inc同比增速更快（2.2% vs -1.7%），过去两年MSA Safety Inc的营收复合增速更高（11.2% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
MSA安全是美国专业安全设备生产供应商，面向建筑、军事、消防、化工、油气等存在高危作业场景的多个行业提供安全防护产品及解决方案，总部位于美国匹兹堡近郊的克兰伯里。
MD vs MSA — 直观对比
营收规模更大
MSA
是对方的1.0倍
$493.8M
营收增速更快
MSA
高出4.0%
-1.7%
净利率更高
MSA
高出10.2%
6.8%
两年增速更快
MSA
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $510.9M |
| 净利润 | $33.7M | $86.9M |
| 毛利率 | — | 46.9% |
| 营业利润率 | 9.9% | 22.3% |
| 净利率 | 6.8% | 17.0% |
| 营收同比 | -1.7% | 2.2% |
| 净利润同比 | 10.5% | -1.2% |
| 每股收益（稀释后） | $0.40 | $2.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDMSA
| Q4 25 | $493.8M | $510.9M | ||
| Q3 25 | $492.9M | $468.4M | ||
| Q2 25 | $468.8M | $474.1M | ||
| Q1 25 | $458.4M | $421.3M | ||
| Q4 24 | $502.4M | $499.7M | ||
| Q3 24 | $511.2M | $432.7M | ||
| Q2 24 | $504.3M | $462.5M | ||
| Q1 24 | $495.1M | $413.3M |
净利润MDMSA
| Q4 25 | $33.7M | $86.9M | ||
| Q3 25 | $71.7M | $69.6M | ||
| Q2 25 | $39.3M | $62.8M | ||
| Q1 25 | $20.7M | $59.6M | ||
| Q4 24 | $30.5M | $87.9M | ||
| Q3 24 | $19.4M | $66.6M | ||
| Q2 24 | $-153.0M | $72.2M | ||
| Q1 24 | $4.0M | $58.1M |
毛利率MDMSA
| Q4 25 | — | 46.9% | ||
| Q3 25 | — | 46.5% | ||
| Q2 25 | — | 46.6% | ||
| Q1 25 | — | 45.9% | ||
| Q4 24 | — | 46.9% | ||
| Q3 24 | — | 47.9% | ||
| Q2 24 | — | 48.2% | ||
| Q1 24 | — | 47.3% |
营业利润率MDMSA
| Q4 25 | 9.9% | 22.3% | ||
| Q3 25 | 13.8% | 20.1% | ||
| Q2 25 | 12.8% | 18.1% | ||
| Q1 25 | 7.0% | 18.5% | ||
| Q4 24 | 7.8% | 23.5% | ||
| Q3 24 | 6.6% | 21.1% | ||
| Q2 24 | -31.3% | 21.6% | ||
| Q1 24 | 3.2% | 19.4% |
净利率MDMSA
| Q4 25 | 6.8% | 17.0% | ||
| Q3 25 | 14.5% | 14.9% | ||
| Q2 25 | 8.4% | 13.2% | ||
| Q1 25 | 4.5% | 14.1% | ||
| Q4 24 | 6.1% | 17.6% | ||
| Q3 24 | 3.8% | 15.4% | ||
| Q2 24 | -30.3% | 15.6% | ||
| Q1 24 | 0.8% | 14.1% |
每股收益（稀释后）MDMSA
| Q4 25 | $0.40 | $2.22 | ||
| Q3 25 | $0.84 | $1.77 | ||
| Q2 25 | $0.46 | $1.59 | ||
| Q1 25 | $0.24 | $1.51 | ||
| Q4 24 | $0.37 | $2.22 | ||
| Q3 24 | $0.23 | $1.69 | ||
| Q2 24 | $-1.84 | $1.83 | ||
| Q1 24 | $0.05 | $1.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | $165.1M |
| 总债务越低越好 | $570.5M | $580.9M |
| 股东权益账面价值 | $865.9M | $1.4B |
| 总资产 | $2.2B | $2.6B |
| 负债/权益比越低杠杆越低 | 0.66× | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资MDMSA
| Q4 25 | $375.2M | $165.1M | ||
| Q3 25 | $340.1M | $170.0M | ||
| Q2 25 | $224.7M | $147.0M | ||
| Q1 25 | $99.0M | $170.6M | ||
| Q4 24 | $229.9M | $164.6M | ||
| Q3 24 | $103.8M | $154.4M | ||
| Q2 24 | $19.4M | $146.8M | ||
| Q1 24 | $8.0M | $148.3M |
总债务MDMSA
| Q4 25 | $570.5M | $580.9M | ||
| Q3 25 | $577.2M | $628.6M | ||
| Q2 25 | $583.9M | $679.3M | ||
| Q1 25 | $590.5M | $502.1M | ||
| Q4 24 | $597.1M | $508.0M | ||
| Q3 24 | — | $554.7M | ||
| Q2 24 | — | $588.2M | ||
| Q1 24 | — | $596.2M |
股东权益MDMSA
| Q4 25 | $865.9M | $1.4B | ||
| Q3 25 | $890.7M | $1.3B | ||
| Q2 25 | $833.8M | $1.3B | ||
| Q1 25 | $789.2M | $1.2B | ||
| Q4 24 | $764.9M | $1.1B | ||
| Q3 24 | $732.5M | $1.1B | ||
| Q2 24 | $706.5M | $1.0B | ||
| Q1 24 | $856.2M | $994.8M |
总资产MDMSA
| Q4 25 | $2.2B | $2.6B | ||
| Q3 25 | $2.2B | $2.6B | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.0B | $2.2B | ||
| Q4 24 | $2.2B | $2.2B | ||
| Q3 24 | $2.1B | $2.2B | ||
| Q2 24 | $2.0B | $2.2B | ||
| Q1 24 | $2.2B | $2.2B |
负债/权益比MDMSA
| Q4 25 | 0.66× | 0.42× | ||
| Q3 25 | 0.65× | 0.48× | ||
| Q2 25 | 0.70× | 0.54× | ||
| Q1 25 | 0.75× | 0.42× | ||
| Q4 24 | 0.78× | 0.44× | ||
| Q3 24 | — | 0.51× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | — | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $122.4M |
| 自由现金流经营现金流 - 资本支出 | — | $106.0M |
| 自由现金流率自由现金流/营收 | — | 20.8% |
| 资本支出强度资本支出/营收 | — | 3.2% |
| 现金转化率经营现金流/净利润 | 3.39× | 1.41× |
| 过去12个月自由现金流最近4个季度 | — | $295.4M |
8季度趋势，按日历期对齐
经营现金流MDMSA
| Q4 25 | $114.1M | $122.4M | ||
| Q3 25 | $137.3M | $112.5M | ||
| Q2 25 | $137.2M | $67.2M | ||
| Q1 25 | $-117.5M | $61.8M | ||
| Q4 24 | $133.0M | $107.9M | ||
| Q3 24 | $91.8M | $84.3M | ||
| Q2 24 | $107.0M | $53.3M | ||
| Q1 24 | $-125.2M | $50.9M |
自由现金流MDMSA
| Q4 25 | — | $106.0M | ||
| Q3 25 | — | $100.5M | ||
| Q2 25 | — | $37.9M | ||
| Q1 25 | — | $51.0M | ||
| Q4 24 | — | $93.5M | ||
| Q3 24 | — | $70.1M | ||
| Q2 24 | — | $39.0M | ||
| Q1 24 | — | $39.7M |
自由现金流率MDMSA
| Q4 25 | — | 20.8% | ||
| Q3 25 | — | 21.4% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | 12.1% | ||
| Q4 24 | — | 18.7% | ||
| Q3 24 | — | 16.2% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 9.6% |
资本支出强度MDMSA
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 2.6% | ||
| Q4 24 | — | 2.9% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 2.7% |
现金转化率MDMSA
| Q4 25 | 3.39× | 1.41× | ||
| Q3 25 | 1.91× | 1.62× | ||
| Q2 25 | 3.49× | 1.07× | ||
| Q1 25 | -5.66× | 1.04× | ||
| Q4 24 | 4.36× | 1.23× | ||
| Q3 24 | 4.72× | 1.27× | ||
| Q2 24 | — | 0.74× | ||
| Q1 24 | -31.03× | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
MSA
| Americas Segment | $335.2M | 66% |
| International Segment | $175.7M | 34% |
